Human Serum Albumin as an Antioxidant in the Oxidation of (−)-Epigallocatechin Gallate: Participation of Reversible Covalent Binding for Interaction and Stabilization

  • ISHII Takeshi
    Department of Food and Nutritional Sciences, and Global Center of Excellence (COE) Program, University of Shizuoka
  • ICHIKAWA Tatsuya
    Department of Food and Nutritional Sciences, and Global Center of Excellence (COE) Program, University of Shizuoka
  • MINODA Kanako
    Department of Food and Nutritional Sciences, and Global Center of Excellence (COE) Program, University of Shizuoka
  • KUSAKA Koji
    Department of Food and Nutritional Sciences, and Global Center of Excellence (COE) Program, University of Shizuoka
  • ITO Sohei
    Department of Food and Nutritional Sciences, and Global Center of Excellence (COE) Program, University of Shizuoka
  • SUZUKI Yukiko
    ULVAC, Inc.
  • AKAGAWA Mitsugu
    Department of Biological Chemistry, Division of Applied Life Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University
  • MOCHIZUKI Kazuki
    Department of Food and Nutritional Sciences, and Global Center of Excellence (COE) Program, University of Shizuoka
  • GODA Toshinao
    Department of Food and Nutritional Sciences, and Global Center of Excellence (COE) Program, University of Shizuoka
  • NAKAYAMA Tsutomu
    Department of Food and Nutritional Sciences, and Global Center of Excellence (COE) Program, University of Shizuoka

書誌事項

タイトル別名
  • Human Serum Albumin as an Antioxidant in the Oxidation of (-)-Epigallocatechin Gallate: Participation of Reversible Covalent Binding for Interaction and Stabilization

この論文をさがす

抄録

Human serum albumin (HSA) contributes to the stabilization of (−)-epigallocatechin gallate (EGCg) in serum. We characterize in the present study the mechanisms for preventing EGCg oxidation by HSA. EGCg was stable in human serum or buffers with HSA, but (−)-epigallocatechin (EGC) was unstable. We show by comparing EGCg and EGC in a neutral buffer that EGCg had a higher binding affinity than EGC. This indicates that the galloyl moiety participated in the interaction of EGCg with HSA and that this interaction was of critical importance in preventing EGCg oxidation. The binding affinity of EGCg for HSA and protein carbonyl formation in HSA were enhanced in an alkaline buffer. These results suggest the reversible covalent modification of EGCg via Schiff-base formation, and that the immobilization of EGCg to HSA, through the formation of a stable complex, prevented the polymerization and decomposition of EGCg in human serum.

収録刊行物

被引用文献 (9)*注記

もっと見る

参考文献 (50)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ